×
About 14,686 results

ALLMedicine™ Cardiac Resynchronization Therapy Center

Research & Reviews  6,893 results

The CHA2DS2-VASc Score and Its Association with Long-Term Outcome in a Cardiac Resynchr...
https://doi.org/10.1159/000513955
Cardiology Reitan C, Platonov PG et. al.

May 9th, 2021 - Cardiac resynchronization therapy (CRT) is commonly used in patients with heart failure and left ventricular dyssynchrony. Several scoring systems have been tested in order to predict long-term outcome. Although intended for use in patients with a...

Gain in Real-World Cardiac Resynchronization Therapy Efficacy with SyncAV Dynamic Optim...
https://doi.org/10.1016/j.hrthm.2021.05.006
Heart Rhythm; Varma N, Hu Y et. al.

May 9th, 2021 - SyncAV™, a device-based cardiac resynchronization therapy (CRT) algorithm, promotes electrical optimization by dynamically adjusting atrioventricular intervals. Evaluate impact of SyncAV™ on heart failure hospitalizations (HFH) and related costs i...

Comparative Trial of the Effects of Left Ventricular and Biventricular Pacing on Indice...
https://doi.org/10.1177/00033197211012520
Angiology Dilaveris P, Antoniou CK et. al.

May 3rd, 2021 - Nonresponse to cardiac resynchronization therapy (CRT) has been related with right ventricular dysfunction. Ventriculoarterial coupling (VAC) assesses energy efficiency of the failing heart and stroke work maximization for a given contractility, f...

Five-year survival and use of hospital services following ICD and CRT implantation: com...
https://doi.org/10.1002/ehf2.13357
ESC Heart Failure; Bottle A, Faitna P et. al.

May 1st, 2021 - Guidelines recommend the use of an implantable cardioverter-defibrillator (ICD) and/or cardiac resynchronization therapy (CRT) device based on the results of randomized controlled trials (RCTs), typically with selected patients and short follow-up...

Parameter variations in personalized electrophysiological models of human heart ventric...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8081243
PloS One; Ushenin K, Kalinin V et. al.

Apr 28th, 2021 - The objectives of this study were to evaluate the accuracy of personalized numerical simulations of the electrical activity in human ventricles by comparing simulated electrocardiograms (ECGs) with real patients' ECGs and analyzing the sensitivity...

see more →

Guidelines  7 results

Cardiac Resynchronization Therapy: An Overview on Guidelines.
https://doi.org/10.1016/j.ccep.2015.08.015
Cardiac Electrophysiology Clinics; Boriani G, Nesti M et. al.

Nov 25th, 2015 - Cardiac resynchronization therapy (CRT) is included in international consensus guidelines as a treatment with proven efficacy in well-selected patients on top of optimal medical therapy. Although all the guidelines strongly recommend CRT for LBBB ...

Canadian Cardiovascular Society guidelines on the use of cardiac resynchronization ther...
https://doi.org/10.1016/j.cjca.2013.09.009
The Canadian Journal of Cardiology; Parkash R, Philippon F et. al.

Nov 4th, 2013 - Recent studies have provided the impetus to update the recommendations for cardiac resynchronization therapy (CRT). This article provides guidance on the implementation of CRT and is intended to serve as a framework for the implementation of CRT w...

2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy: the Task F...
https://doi.org/10.1093/eurheartj/eht150
European Heart Journal; Brignole M, Auricchio A et. al.

Jun 26th, 2013 - 2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy: the Task Force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Asso...

2012 EHRA/HRS expert consensus statement on cardiac resynchronization therapy in heart ...
https://doi.org/10.1016/j.hrthm.2012.07.025
Heart Rhythm; , et. al.

Sep 3rd, 2012 - 2012 EHRA/HRS expert consensus statement on cardiac resynchronization therapy in heart failure: implant and follow-up recommendations and management.|2012| , , , , ,|instrumentation,methods,standards,methods,standards,instrumentation,methods,stand...

2012 EHRA/HRS Expert Consensus Statement on Cardiac Resynchronization Therapy in Heart Failu...
https://www.hrsonline.org/Policy-Payment/Clinical-Guidelines-Documents/2012-Expert-Consensus-Statement-on-CRT
Heart Rhythm Society

Jul 31st, 2012 - The expert consensus statement provides recommendations for the practical management of Cardiac Resynchronization Therapy (CRT) patients before, during and after the implantation procedure. The statement does not discuss clinical indications for C.

see more →

Clinicaltrials.gov  7,295 results

The CHA2DS2-VASc Score and Its Association with Long-Term Outcome in a Cardiac Resynchr...
https://doi.org/10.1159/000513955
Cardiology Reitan C, Platonov PG et. al.

May 9th, 2021 - Cardiac resynchronization therapy (CRT) is commonly used in patients with heart failure and left ventricular dyssynchrony. Several scoring systems have been tested in order to predict long-term outcome. Although intended for use in patients with a...

Gain in Real-World Cardiac Resynchronization Therapy Efficacy with SyncAV Dynamic Optim...
https://doi.org/10.1016/j.hrthm.2021.05.006
Heart Rhythm; Varma N, Hu Y et. al.

May 9th, 2021 - SyncAV™, a device-based cardiac resynchronization therapy (CRT) algorithm, promotes electrical optimization by dynamically adjusting atrioventricular intervals. Evaluate impact of SyncAV™ on heart failure hospitalizations (HFH) and related costs i...

Comparative Trial of the Effects of Left Ventricular and Biventricular Pacing on Indice...
https://doi.org/10.1177/00033197211012520
Angiology Dilaveris P, Antoniou CK et. al.

May 3rd, 2021 - Nonresponse to cardiac resynchronization therapy (CRT) has been related with right ventricular dysfunction. Ventriculoarterial coupling (VAC) assesses energy efficiency of the failing heart and stroke work maximization for a given contractility, f...

Five-year survival and use of hospital services following ICD and CRT implantation: com...
https://doi.org/10.1002/ehf2.13357
ESC Heart Failure; Bottle A, Faitna P et. al.

May 1st, 2021 - Guidelines recommend the use of an implantable cardioverter-defibrillator (ICD) and/or cardiac resynchronization therapy (CRT) device based on the results of randomized controlled trials (RCTs), typically with selected patients and short follow-up...

Parameter variations in personalized electrophysiological models of human heart ventric...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8081243
PloS One; Ushenin K, Kalinin V et. al.

Apr 28th, 2021 - The objectives of this study were to evaluate the accuracy of personalized numerical simulations of the electrical activity in human ventricles by comparing simulated electrocardiograms (ECGs) with real patients' ECGs and analyzing the sensitivity...

see more →

News  491 results

Keeping Pace: His-Bundle CRT for Heart Failure Impresses in Second Randomized Trial
https://www.medscape.com/viewarticle/950037

Apr 26th, 2021 - The limitations of biventricular (BiV) pacing, successful as it has been at improving cardiac function and outcomes in many patients with heart failure, leave opportunities for more physiologic pacing alternatives to drive cardiac resynchronizatio...

Medtronic Recalls Evera, Viva, Brava, Claria, Amplia, Compia, and Visia Implantable Cardioverter Defibrillators (ICDs) and Cardiac Resynchronization Therapy (CRT-Ds) Due to Risk of Shortened Batter...
https://www.fda.gov/medical-devices/medical-device-recalls/medtronic-recalls-evera-viva-brava-claria-amplia-compia-and-visia-implantable-cardioverter

The FDA has identified this as a Class I recall, the most serious type of recall. Use of these devices may cause serious injuries or death. Recalled Product Medtronic Evera, Viva, Brava, Claria, Amplia, Compia, and Visia Implantable Cardioverter D...

Medtronic Recall of Almost 240,000 ICDs Is Class I, FDA Says
https://www.medscape.com/viewarticle/949125

Apr 11th, 2021 - The US Food and Drug Administration has declared Medtronic's recall of seven models of defibrillating cardiac rhythm devices, due to a risk for premature battery depletion, as Class I, which implies a potential risk for serious injury or death. A ...

First Experience With Completely Leadless CRT
https://www.medscape.com/viewarticle/943253

Dec 27th, 2020 - Totally leadless cardiac resynchronization therapy (CRT) combining the Micra transcatheter pacing system and a WiSE-CRT system was feasible and associated with significant acute QRS reduction in a small, nonrandomized, retrospective study. Six mon...

Obesity Independently Tied to Longer Survival After Cardiac Resynchronization
https://www.medscape.com/viewarticle/940580

Nov 9th, 2020 - NEW YORK (Reuters Health) - Obesity is associated with longer survival after cardiac resynchronization therapy (CRT) regardless of improvements in left ventricular ejection fraction (LVEF), according to a new study. Previous studies have found an ...

see more →